- Name: Li Qiwen
- Title: M.D., Associate Professor, Advisor of Master's Degree students
- Email: liqw@sysucc.org.cn
- Phone:
Profile
Dr. Li Qiwen has been working in Sun Yat-Sen University Cancer Center since 2013. She is currently an associate professor in the Department of Radiation Oncology. Her work focused on the treatment and research of thoracic tumors. She participates in phase I and II clinical trials optimizing chemoradiation strategy in lung and esophageal cancer. She also contributes in the theoretical improvement of outcome prediction in patients receiving radiotherapy. She is funded by Natural Science Foundation of Guangdong Province of China as a principal investigator.
Interests
Lung cancer, esophageal cancer and mediastinal tumors
Education
2005-2013 studied clinical medicine in Shanghai Medical College, Fudan University and received an M.D. degree.
Publications
1. Li QW, Qiu B, Wang B, Zhang J, Chen L, Zhou Y, Qin JK, Guo SP, Xie WH, Hui ZG, Liang Y, Guo JY, Wang H, Zhu M, Shen WT, Duan LY, Chen LK, Zhang L, Long H, Wang YM, Liu H. Comparison of hyper- and hypofractionated radiation schemes with IMRT technique in small cell lung cancer: Clinical outcomes and the introduction of extended LQ and TCP models. Radiother Oncol. 2019;136:98-105.
2. Li QW, Qiu B, Hu WM, Guo SP, Wu YJ, Zhu YJ, Hu N, Ai XL, Chen NB, Guo JY, Hu YH, Liu MZ, Zeng MS, Liu H. Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma. Front Oncol. 2020;10:1487.
3. Li QW, Qiu B, Liang WH, Wang JY, Hu WM, Zhang T, Xu SB, López J, Chen NB, Guo MZ, Zhao Y, Chen LJ, Liu SR, Yun JP, Guo JY, Wang SY, Wang X, Zhang L, Yue DS, Liao ZX, Lin SH, Long H, Pang QS, Liu H. Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study. J Cancer. 2020;11(20):6114-6121.
4. Li QW, Qiu B, Wang B, Wang DL, Yin SH, Yang H, Liu JL, Fu JH, Liu MZ, Xie CM, Liu H. Prediction of pathological responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study. Dis Esophagus. 2018;31.
5. Qiu B, Li Q, Liu J, Huang Y, Pang Q, Zhu Z, Yang X, Wang B, Chen L, Fang J, Lin M, Jiang X, Guo S, Guo J, Wang D, Liu F, Chu C, Huang X, Xie C, Liu H. Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial. Int J Radiat Oncol Biol Phys. 2021;111(2):424-435.
6. Chen N, Li Q, Wang S, Xiong M, Luo Y, Wang B, Chen L, Lin M, Jiang X, Fang J, Guo S, Guo J, Hu N, Ai X, Wang D, Chu C, Liu F, Long H, Wang J, Qiu B, Liu H. Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017). Lung Cancer. 2021;156:82-90.
7. Chen NB, Li QW, Li S, Guo SP, Wu YJ, Cheng ZK, Li JB, Wang DQ, Liu FJ, Ai XL, Hu N, Qiu B, Liu H. Docetaxel and nedaplatin twice a week with concurrent definitive radiotherapy in inoperable esophageal squamous cell carcinoma: a phase I trial (GASTO-1021). Radiother Oncol. 2020;S0167-8140(20)30882-3.
8. Chen B, Li Q, Li Q, Qiu B, Xi M, Liu M, Hu Y, Zhu Y. Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study. Oncologist. 2020;25(4):308-e625.
9. Qiu B, Li QW, Ai XL, Wang B, Huan J, Zhu ZF, Yu GH, Ji M, Jiang HH, Li C, Zhang J, Chen L, Guo JY, Zhou Y, Liu H. Investigating the loco-regional control of simultaneous integrated boost intensity-modulated radiotherapy with different radiation fraction sizes for locally advanced non-small-cell lung cancer: clinical outcomes and the application of an extended LQ/TCP model. Radiat Oncol. 2020;15(1):124.
10. Qiu B, Wang D, Li Q, Wu Y, Guo S, Jiang X, Fang J, Guo J, Liu F, Chu C, Wang B, Chen L, Zhang J, Liu Y, Hu Y, Liu H. Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys. 2021;111(4):917-925.
Updated November 2021 by International Office, Sun Yat-sen University Cancer Center